Schedule-dependent synergism and antagonism between methotrexate and 6-mercaptopurine in a human acute lymphoblastic cell line

This publication has 12 references indexed in Scilit:

• Systemic Exposure to Mercaptopurine as a Prognostic Factor in Acute Lymphocytic Leukemia in Children
  New England Journal of Medicine, 1990
• The effect of methotrexate on the bioavailability of oral 6-mercaptopurine
  Clinical Pharmacology & Therapeutics, 1987
• Synergy of Methotrexate and 6-Mercaptopurine on Cell Growth and Clono- Genicity of Cultured Human T-Lymphoblasts
  Published by Springer Nature ,1986
• Increased Availability of Phosphoribosyl Pyrophosphate as the Basis for Enhanced 6-Mercaptopurine Incorporation by Methotrexate, in Cultured Human Lymphoblasts
  Published by Springer Nature ,1986
• Enhancement of 6-thioguanine cytotoxic activity with methotrexate
  Biochemical and Biophysical Research Communications, 1982
• Some biochemical characteristics of L1210 cell lines resistant to 6-mercaptopurine and 6-thioguanine and with increased sensitivity to methotrexate
  Biochemical Pharmacology, 1982
• Enhanced 5-Fluorouracil Nucleotide Formation After Methotrexate Administration: Explanation for Drug Synergism
  Science, 1979
• Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity
  International Journal of Radiation Oncology*Biology*Physics, 1979
• Comparative Study of 6-Mercaptopurine Metabolism in Human Leukemic Leukocytes and L1210 Cells
  Antimicrobial Agents and Chemotherapy, 1977
• RESPONSE OF ACUTE LYMPHOCYTIC LEUKEMIAS TO THE PURINE ANTAGONIST 6‐MERCAPTOPURINE
  Annals of the New York Academy of Sciences, 1954